Acorah Software Products - Accounts Production 16.5.460 false true 31 March 2024 1 April 2023 false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 11902226 Mr Basil Mohammed iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11902226 2024-03-31 11902226 2025-03-31 11902226 2024-04-01 2025-03-31 11902226 frs-core:CurrentFinancialInstruments 2025-03-31 11902226 frs-core:Non-currentFinancialInstruments 2025-03-31 11902226 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11902226 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 11902226 frs-bus:Micro-entities 2024-04-01 2025-03-31 11902226 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11902226 frs-bus:Director1 2024-04-01 2025-03-31 11902226 2023-03-31 11902226 2024-03-31 11902226 2023-04-01 2024-03-31 11902226 frs-core:CurrentFinancialInstruments 2024-03-31 11902226 frs-core:Non-currentFinancialInstruments 2024-03-31
Registered number: 11902226
AEM Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 March 2025
Sam & Co Accountants
AEM Pharma Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 11902226

| 2025 | 2024
--- | --- | ---
|  | £ | £
Fixed assets |  | 1,421 | 1,894
Current assets |  | 24,166 | 34,931
Creditors: Amounts Falling Due Within One Year |  | (18,307 ) | (18,185 )
NET CURRENT ASSETS |  | 5,859 | 16,746
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 7,280 | 18,640
Creditors: Amounts Falling Due After More Than One Year |  | (1,349 ) | (1,400 )
NET ASSETS |  | 5,931 | 17,240
CAPITAL AND RESERVES |  | 5,931 | 17,240

## Notes

1. General Information
AEM Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11902226 . The registered office is Flat 27d Quay 5 Buildings, 238 Ordsall Lane, Salford, M5 3NE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
3. Directors Advances, Credits and Guarantees
Dividends paid to director
Dividend paid to shareholder: Mrs Reela Osman £15,160

| 2025 | 2024
--- | --- | ---
| £ | £
Mr Basil Mohammed | 37,700 | 36,000

Page 0
Page 1
AEM Pharma Limited
Balance Sheet (continued)
As At 31 March 2025
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Basil Mohammed Director
01/07/2025